New Day Diagnostics’s acquisition agreement of Epigenomics approved
Under the agreement, Epigenomics had to sell nearly all its held assets to New Day Diagnostics. Credit: TippaPatt/Shutterstock. Diagnostic healthcare company New Day Diagnostics has announced the approval of an agreement to acquire Epigenomics to provide accessible and innovative diagnostic solutions. An extraordinary general meeting (EGM) of Epigenomics had to approve the agreement, which was a crucial […]
Natera announces Signatera test use in new I-SPY 2 trial
The test helps identify and quantify cancer left in the body, even at levels down to a single tumour molecule in a tube of blood. Credit: Ahmad Ardity from Pixabay. Natera has announced the use of its personalised and tumour-informed molecular residual disease (MRD) test, Signatera, in a new study as part of the I-SPY […]
Organon publishes post-market study of JADA PPH control system
The JADA system uses low-level vacuum technology to encourage contraction and control uterine bleeding. Image Credit: JGI/Jamie Grill / Getty Images. Organon has published the results of a real-world study, which used the JADA system to treat abnormal postpartum uterine bleeding and postpartum haemorrhage (PPH). The results from the post-market registry RUBY (NCT04995887) were published […]
Signal: Danaher’s $5.7bn acquisition of Abcam faces stand-off with founder
Abcam was founded in 1998 and has been called the “Amazon of antibodies”. Photo: Shutterstock. Abcam’s $5.7bn acquisition by multi-national conglomerate Danaher may be blocked by shareholders after the company’s founder declared his intention to vote against the deal. Jonathan Milner, founder and ex-CEO of the UK-based antibody and protein manufacturer, announced yesterday (14 September) […]
Beacon receives US FDA approval for sleep monitoring device
The Dreem3S advanced wearable headband. Credit: Beacon Biosignals/PRNewswire. Beacon Biosignals has received 510(k) clearance from the US Food and Drug Administration (FDA) for its artificial intelligence-assisted sleep monitoring device, Dreem 3S. The new wearable headband with integrated machine learning algorithms will help acquire electroencephalogram (EEG) data from the brain for monitoring sleep architecture and assisting […]
NovaBay Pharmaceuticals introduces optic allograft in US
The allograft offers a protective environment or covering for repair of the cornea and conjunctiva. Credit: 4 PM production / Shutterstock.com. NovaBay Pharmaceuticals has commercially introduced its optic Avenova Allograft for eyecare professionals in the US. Available through the company’s physician-dispensed channel, the optic allograft can be used as a protective covering during the repair […]
Bionik receives US patent for new rehabilitation technology
The new technology will help improve the rehabilitation process for people recovering from neurological injuries and conditions. Credit: Africa Studio / Shutterstock.com. Bionik Laboratories has secured a patent from the US Patent and Trademark Office (USPTO) for its innovative rehabilitation technology. The latest patent, titled “An Apparatus and/or Method for Positioning a Hand for Rehabilitation”, […]
No more cookies: How healthcare companies can gain trust for data consent
Data is a valuable commodity in an age of data-driven marketing, but considerable care must be taken when collecting sensitive information in healthcare. Businesses rely on third-party data about their audiences that is usually collected through cookies. While such third-party cookies and pixel-tracking technologies are useful for targeted advertising, a lack of transparency has made […]
FDA label Abbott Medical recall as Class I
There have been 186 reported incidents of faulty devices and 76 cases of injuries from the Class I recall. credit: Shutterstock/Drozd Irina Abbott Medical is recalling its Proclaim neurostimulation systems and Infinity IPGs after receiving complaints that users were unable the exit the magnetic resonance imaging (MRI) mode. On 13 September, the US Food and Drug […]
Nemaura reveals interim results from UK clinical trial of Miboko app
The primary objective of the study was to evaluate the subject’s engagement level and weight reduction upon using Miboko and daily wear continuous glucose monitoring (CGM). Image Credit: Africa Studio / Shutterstock. Interim results from a study of Nemaura Medical’s Miboko (Mind, Body, Konnect) app show users lost an average of 2.9kg after 20 weeks […]